Clicky

Turn On, Tune In, and…. Heal Your Brain? Psychedelics Return as Potential Therapy for Mental Health Disorders

pharmacists giving out trusted info to a patient

Before they fell out of favor over half a century ago, psychedelic drugs, like psilocybin and LSD, were studied for various psychiatric diseases such as alcoholism and heroin addiction. Due to promising results and governmental approval to utilize therapy, there is a growing interest in the pharmacologic properties of these drugs. The use of psychedelic therapy offers new hope in individuals who are often left with limited choices due to side effects or treatment failure.

Share This Post

Sonja was twelve years old when the car accident happened. She survived, but her family didn’t. For years, she could not escape the horrible reality that she called life. She suffered from debilitating dreams, where she vividly relived “flashbacks” of the event. She ended up finding a career where she could work from home because getting into a vehicle of any kind was simply out of the question.

She tried to get help and was diagnosed with PTSD (Post-traumatic stress disorder). She went from therapist to therapist and tried medication after medication. 

No relief.

She felt so ALONE. So isolated.

As she sank deeper and deeper, she turned to alcohol and cigarettes to numb the pain. It didn’t solve the problem, but at least took the edge off.

Finally, after watching a documentary about something called ‘psychedelic therapy,’ she had new hope. She ran the idea past her aunt, who expressed concern. “Honey, I knew people who tried that in my day. It was bad news. Some of them had what we called “a bad trip” and were never the same.” She valued her aunt’s opinion but decided to trust her gut and enrolled in this new therapy.

Thanks to new developments in brain imagining technology, the understanding of the human brain have come a long way in the last 20 years. Discovery of an area known as the default mode network, involved in brain processes such as daydreaming, thinking of the future, and recalling memories has sparked a renewed interest in psychedelics as potential drug therapies.

Psychedelic Use in The Past

In the 1950s, researchers began to conduct studies focused on the therapeutic effects of psychedelics.

Psilocybin and LSD, which work on similar receptors, were widely studied in more than 40,000 people for their use in substance use disorders. Some were in controlled therapeutic settings, but some were also used unethically.

The counterculture movement and fear of increased drug use led to the ban of LSD in 1968.

The Controlled Substances Act in 1970 soon followed, and all research on psychedelic use in humans came to a halt. It wasn’t until the turn of the century, in 2000, that things began to turn around.

Johns Hopkins Center for Psychedelic & Consciousness Research

In 2000, a research group at Johns Hopkins University was the first to secure regulatory approval in the United States to reinstitute research with psychedelics In healthy volunteers.

In 2006, they published a monumental study showing a single dose was safe and had lasting positive effects.

This study was followed ten years later with another study showing that psilocybin significantly decreased depression and anxiety in patients with terminal cancer.

YouTube player

How do Psychedelics Work?

The exact mechanism of how psychedelics work in the brain is not well understood.

Researchers have theorized that the agents work on the area known as the default mode network, enabling patients to experience “loss of self” or “ego dissolution.

What is known is that the use of the drug is only part of the equation.

Effective psychedelic therapy requires intense therapy with a trained therapist to allow integration of the experience.

In November 2019, officials in Oregon approved a 2020 ballot measure that would allow medical professionals to conduct psilocybin-assisted therapy.

If it passes, Oregon will be the first state to let licensed therapists administer psilocybin. Other states like California are likely to follow suit.

Which Individuals Should NOT Use Psychedelics?

There is a population of individuals, such as those who have schizophrenia, who should not be given psychedelic therapy.

Also, these types of drugs can increase blood pressure, so those suffering from uncontrolled hypertension should not partake in psychedelic therapy.

Risk can also be minimized by carefully selecting the patient and giving it in a controlled environment where the patient feels safe.

Breakthrough Therapy Designation by FDA

Several other institutions, such as the Multidisciplinary Association for Psychedelic Studies (MAPS), the Usona Institute, and Compass Pathways, are each working towards acquiring U.S. Food and Drug Administration (FDA) approval of investigational psychedelic medicine.

Presently, both MDMA (another psychedelic) and psilocybin have been granted Breakthrough Therapy Designation by the FDA.

Breakthrough status is granted when early clinical evidence suggests that the agent being studied may offer substantial benefits over existing therapies for serious conditions.

So, the FDA commits to expediting the development and review of these agents as a result.

Another leader in experimental psychedelic clinical research, COMPASS Pathways, is testing the safety and efficacy of psilocybin-assisted therapy for treatment-resistant depression.

They also have a similar study for psychedelic use in obsessive-compulsive disorder.

The Future of Psychedelic Drug Therapy

Research continues in areas such as smoking cessation, anorexia nervosa, Alzheimer’s Disease, and individuals who have PTSD (Post-traumatic stress disorder).

You can read more about the research and trials here. The most significant barrier to future research is the availability of funding.

Due to the uncertainty of the drug’s legal status, it is challenging to conduct costly research. In the interim, some gain tremendous benefit from therapy.

References, Studies and Sources:

Anderson A, LSD May Chip Away at the Brain’s “Sense of Self” Network. Scientific American website. Published April 16, 2013. https://www.scientificamerican.com/article/lsd-may-chip-away-at-the-brain-s-sense-of-self-network/. Accessed 1 July 2020.

Cooper A. Psilocybin Sessions: Psychedelics could help people with addiction and anxiety. CBS News website. December 29, 2019. https://www.cbsnews.com/news/psychedelic-drugs-lsd-active-agent-in-magic-mushrooms-to-treat-addiction-depression-anxiety-60-minutes-2019-12-29/. Accessed 1 July 2020.

Food and Drug Administration. Breakthrough Therapy. FDA Available from: https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/breakthrough-therapy. Accessed 12 July 2020.

Griffiths RR, Richards WA, McCann U, Jesse R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology (Berl). 2006;187(3):268-292. doi:10.1007/s00213-006-0457-5

Griffiths RR, Johnson MW, Carducci MA, et al. psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. J Psychopharmacol. 2016;30(12):1181-1197. doi:10.1177/0269881116675513

Hale, V. The FDA and Psychedelic Drug Development: Working Together to Make Medicines. MAPS Bulletin Spring 2020: Vol 30, No. 1. MAPS website. Published Spring 2020. https://maps.org/news/bulletin/articles/439-bulletin-spring-2020/8129-the-fda-and-psychedelic-drug-development-working-together-to-make-medicines. Accessed 1 July 2020.

Illing, S. The extraordinary therapeutic potential of psychedelic drugs, explained.Vox website. Published March 8, 2019. https://www.vox.com/science-and-health/2019/1/10/18007558/denver-psilocybin-psychedelic-mushrooms-ayahuasca-depression-mental-health. Accessed 30 June 2020.

Johns Hopkins Center for Psychedelic and Consciousness Research Homepage. https://hopkinspsychedelic.org/. Accessed 1 July 2020.

Lewis, T. Johns Hopkins Scientists Give Psychedelics the Serious Treatment. Scientific American website. Published January 16, 2020. Accessed 29 June 2020. https://www.scientificamerican.com/article/johns-hopkins-scientists-give-psychedelics-the-serious-treatment/

Nutt D. Psychedelic drugs-a new era in psychiatry? Dialogues Clin Neurosci. 2019;21(2):139-147. doi:10.31887/DCNS.2019.21.2/dnutt

Nutt, D et al., Psychedelic Psychiatry’s Brave New World, Cell (2020). DOI: 10.1016/j.cell.2020.03.020

Revisiting the potential of using psychedelic drugs in psychiatry. Medical Xpress website. Published April 2, 2020. https://medicalxpress.com/news/2020-04-revisiting-potential-psychedelic-drugs-psychiatry.html. Accessed 30 June 2020.

We are committed to providing our readers with only trusted resources and science-based studies with regards to medication and health information. 

Disclaimer: This general information is not intended to diagnose any medical condition or to replace your healthcare professional. If you suspect medical problems or need medical help or advice, please talk with your healthcare professional.

Share This Post

Pharmacists.org Discount Club

Get Started for $1.

  • Cheapest cash pay option at your retail pharmacy
  • 1,000s of drugs below $10.00 that can beat your co-pay
  • Start for $1 for your first month. Cancel anytime. 
  • Tell us your meds, we tell you the cheapest options.

Popular Destinations

Recent Articles

Cerebral Review: Online Depression & Anxiety Treatment

Today, we’re deep diving with a Cerebral review to give you some insider info to help you narrow down your choices.


We review and include products we think are useful for our community. If you buy through links on this page, we may earn a commission. For more info, please read our ad policy, content principles and vetting policy.

Read More »

Can You Use Gabapentin For Anxiety?

While Neurontin is the most common brand name for gabapentin, other forms (such as Horizant and Gralise) may be prescribed depending on the specific condition it is being used to treat. Gabapentin has also been shown to help people with insomnia, as difficulty falling or staying asleep is another symptom of chronic anxiety.

Read More »

What is Zoloft?

If you have been recently diagnosed with depression and are given Zoloft, you may want to know how the medication works, what common side effects are, and any risks associated with taking it. Read on to find out these details. 

Read More »

Share On:

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Cerebral Review: Online Depression & Anxiety Treatment

Today, we’re deep diving with a Cerebral review to give you some insider info to help you narrow down your choices.

We review and include

What are the signs of Depression?

In this article, we will discuss the signs and symptoms of depression as well as some treatment options for this condition.

Can You Use Gabapentin For Anxiety?

While Neurontin is the most common brand name for gabapentin, other forms (such as Horizant and Gralise) may be prescribed depending on the specific

Zoloft and Weight Loss: Everything You Need To Know

When it comes to Zoloft and weight loss, here’s everything you need to know.

What is Zoloft?

If you have been recently diagnosed with depression and are given Zoloft, you may want to know how the medication works, what common side

What is Venlafaxine HCL ER?

The prescription drug belongs to a class of drugs called selective serotonin norepinephrine reuptake inhibitor antidepressants (SNRIs), which are commonly used to treat mental

Using Prozac With Alcohol: What Are the Risks?

Prozac can be used to treat many different mental health conditions, is associated with a relatively low risk of side effects, and causes the

How Long Does Clonazepam Stay in Your System?

This fast-acting medication is known for being effective at panic attacks, but how long does clonazepam stay in your system?

What is Sertraline and What are the Side Effects?

Sertraline is the generic form of Zoloft, a medication that belongs to a class of drugs called selective serotonin reuptake inhibitors (SSRIs). SSRIs like

How Long Does Alprazolam Stay in Your System?

Alprazolam is a fast-acting medication, but exactly how long alprazolam stays in your body varies tremendously based on the form of the medication taken,

Paxil vs Zoloft: Differences, Similarities and Which is Better

When it comes to Paxil vs. Zoloft, which is better?

A Supplement for Stress? The Science Behind Adaptogens

Stress is part of all our lives. Adaptogens are a group of herbal supplements studied throughout history as a way to improve the body’s

Does Buspirone Cause Weight Gain?

Many antidepressants can cause weight gain as a side effect. Buspirone may cause an altered appetite as a side effect, which can lead to

Duloxetine Withdrawal: Symptoms, Timeline, and Treatment

Duloxetine withdrawal is very common and well documented, affecting nearly half of all patients. Common withdrawal symptoms include dizziness, headaches, and nausea, and symptoms

Cymbalta vs. Prozac: Comparison Guide

Cymbalta and Prozac are commonly prescribed medications to treat mental health conditions such as major depressive disorder. The medications are similarly effective, although one

How Long Does Ativan Stay in Your System?

If you use Ativan to manage your health but are curious about how long Ativan lasts in your system, we have all the information

Why is Mental Health Important?

As the saying goes, “There is no health without mental health,” but why is mental health so important? The reality is that although we

What is BuSpar? Uses, Costs, Benefits, and Doses

If you’re one of 40 million American adults suffering from an anxiety disorder or experiencing symptoms of anxiety, you might think that your battle

What are Long-Acting Injectable Antipsychotics? 

Long-acting injectable (LAI) antipsychotics have been shown to prevent psychosis relapse in patients with schizophrenia. To combat poor medication adherence, LAIs are a great

Cymbalta vs Effexor: Differences and Side Effects

Effexor and Cymbalta are antidepressants used for the treatment of major depressive disorder and generalized anxiety disorder. Although both medications are FDA-approved, Effexor and